HCA Healthcare Q3 2024 Adj. EPS $4.90 Misses $4.96 Estimate, Sales $17.487B Miss $17.538B Estimate
Portfolio Pulse from Benzinga Newsdesk
HCA Healthcare reported its Q3 2024 financial results, with adjusted EPS of $4.90 missing the estimate of $4.96, and sales of $17.487 billion falling short of the expected $17.538 billion.
October 25, 2024 | 11:32 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HCA Healthcare's Q3 2024 earnings report shows a miss on both EPS and sales estimates, which could negatively impact the stock price in the short term.
HCA Healthcare's reported EPS of $4.90 and sales of $17.487 billion both missed analyst expectations. Such misses typically lead to negative investor sentiment and potential short-term stock price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100